Today October 13, 2026

Icotyde psoriasis launch is expected to drive J&J’s growth across indications. Discover the potential impact and future plans.

UK approval for insulin unit marks a significant milestone for Biocon Malaysia.

Aurobindo Pharma inhaler approval brings positive news for the company and patients alike. Discover the details here.

Top